Madeleine J. White

Garscube Estate
Glasgow, SCT G611QH, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Reference gene evaluation for digital PCR; Applications for RNA biomarker testing in cervical precancer.

Reference gene evaluation for digital PCR; Applications for RNA biomarker testing in cervical precancer.

Journal: Journal of virological methods

Published: July 28, 2025

A novel three-dimensional model of infantile haemangioma.

A novel three-dimensional model of infantile haemangioma.

Journal: The British journal of dermatology

Published: September 29, 2024

Recent advances in understanding the molecular basis of infantile haemangioma development.

Recent advances in understanding the molecular basis of infantile haemangioma development.

Journal: The British journal of dermatology

Published: May 05, 2024

The TGF-β mimic TGM4 achieves cell specificity through combinatorial surface co-receptor binding.

The TGF-β mimic TGM4 achieves cell specificity through combinatorial surface co-receptor binding.

Journal: EMBO reports

Published: April 13, 2024

TGM6 is a helminth secretory product that mimics TGF-β binding to TGFBR2 to antagonize signaling in fibroblasts.

TGM6 is a helminth secretory product that mimics TGF-β binding to TGFBR2 to antagonize signaling in fibroblasts.

Journal: Nature communications

Published: March 22, 2024

The tumour microenvironment, treatment resistance and recurrence in glioblastoma.

The tumour microenvironment, treatment resistance and recurrence in glioblastoma.

Journal: Journal of translational medicine

Published: March 19, 2024

TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts.

TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts.

Journal: bioRxiv : the preprint server for biology

Published: January 08, 2024

The helminth TGF-β mimic TGM4 is a modular ligand that binds CD44, CD49d and TGF-β receptors to preferentially target myeloid cells.

The helminth TGF-β mimic TGM4 is a modular ligand that binds CD44, CD49d and TGF-β receptors to preferentially target myeloid cells.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2023

CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimic.

CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimic.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 17, 2023

Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.

Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.

Journal: British journal of cancer

Published: July 23, 2023

Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp-TGM.

Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, Hp-TGM.

Journal: Discovery immunology

Published: August 04, 2022

Oral delivery of a functional algal-expressed TGF-β mimic halts colitis in a murine DSS model.

Oral delivery of a functional algal-expressed TGF-β mimic halts colitis in a murine DSS model.

Journal: Journal of biotechnology

Published: May 18, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026